FDA Approves Phase II Kidney Cancer Therapy Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 9.20 -0.31 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.51 | 52 Week High | $2.18 | |||
| Open | $9.26 | 52 Week Low | $0.30 | |||
| Day High | $9.26 | P/E | N/A | |||
| Day Low | $9.16 | EPS | $-3.32 | |||
| Volume | 11,614 | |||||
